Mechanisms and functions of intestinal vascular specialization.

Authors:
Bernier-Latmani J; González-Loyola A; Petrova TV.

Journal:
J Exp Med

Publication Year: 2023

DOI:
10.1084/jem.20222008

PMCID:
PMC10697212

PMID:
38051275

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Exp Med

Abbreviation: J Exp Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Addendum: Resolvins suppress tumor growth and enhance cancer therapy.
Sulciner ML; Serhan CN; Gilligan MM and 18 more (2024) - Transparency Score: 2/6
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-d…
Ruggiu M; Guérin MV; Corre B and 9 more (2024) - Transparency Score: 3/6
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
Bastard P; Gervais A; Taniguchi M and 87 more (2024) - Transparency Score: 3/6
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.
Wang L; Xiao Y; Luo Y and 19 more (2024) - Transparency Score: 5/6
The effector program of human CD8 T cells supports tissue remodeling.
Delacher M; Schmidleithner L; Simon M and 32 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures: The authors declare no competing interests exist."

Evidence found in paper:

"The authors’ work is supported by grants from the European Union’s Horizon 2020 research and innovation program Theralymph (grant agreement no. 847939), the Swiss National Science Foundation (CR32I3_166326, 310030_212387, and 310030_197878), Fond’action Foundation, Novartis Foundation, and Swiss Cancer League KFS-5685-08-2022 to T.V. Petrova; the Muschamps Foundation and the Swiss National Science Foundation (CRSK-3_190435) to J. Bernier-Latmani; and the European Union-Next Generation EU (MSCA-Seal of Excellence ISCIII-Health IHMC22/00004) to A. González-Loyola."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025